These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8282470)

  • 1. Birthplace as a risk factor in motor neurone disease and Parkinson's disease.
    Betemps EJ; Buncher CR
    Int J Epidemiol; 1993 Oct; 22(5):898-904. PubMed ID: 8282470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson's disease and epilepsy in English populations 1979-2006.
    Goldacre MJ; Duncan M; Griffith M; Turner MR
    J Neurol; 2010 May; 257(5):706-15. PubMed ID: 19946783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
    Pakpoor J; Seminog OO; Ramagopalan SV; Goldacre MJ
    BMC Neurol; 2015 Feb; 15():16. PubMed ID: 25884318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Place of death, and its relation with underlying cause of death, in Parkinson's disease, motor neurone disease, and multiple sclerosis: a population-based study.
    Sleeman KE; Ho YK; Verne J; Glickman M; Silber E; Gao W; Higginson IJ;
    Palliat Med; 2013 Oct; 27(9):840-6. PubMed ID: 23737036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of death certificates for motor neuron disease and multiple sclerosis in the province of Palermo in southern Italy.
    Ragonese P; Salemi G; Aridon P; Conte S; Cuccia G; Lupo I; Savettieri G
    Neuroepidemiology; 2002; 21(3):148-52. PubMed ID: 12006778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies.
    Fois AF; Wotton CJ; Yeates D; Turner MR; Goldacre MJ
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):215-21. PubMed ID: 19726405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing mortality from motor neurone disease and multiple sclerosis in England and Wales and the Republic of Ireland.
    Elian M; Dean G
    Neuroepidemiology; 1992; 11(4-6):236-43. PubMed ID: 1291887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis and motor neurone disease: survival and how certified after death.
    O'Malley F; Dean G; Elian M
    J Epidemiol Community Health; 1987 Mar; 41(1):14-7. PubMed ID: 3668453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in motor neuron disease: association with latitude and air lead levels in Spain.
    Santurtún A; Villar A; Delgado-Alvarado M; Riancho J
    Neurol Sci; 2016 Aug; 37(8):1271-5. PubMed ID: 27098242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa.
    Elian M; Dean G
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):454-7. PubMed ID: 8505633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farming and incidence of motor neuron disease: French nationwide study.
    Kab S; Moisan F; Elbaz A
    Eur J Neurol; 2017 Sep; 24(9):1191-1195. PubMed ID: 28727213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson's disease: age and sex specific rates and cohort analyses.
    Li TM; Swash M; Alberman E
    J Neurol Neurosurg Psychiatry; 1985 Apr; 48(4):320-7. PubMed ID: 3873517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor neuron disease and multiple sclerosis mortality in Australia, New Zealand and South Africa compared with England and Wales.
    Dean G; Elian M
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):633-7. PubMed ID: 8509776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neurone disease and multiple sclerosis among immigrants to Britain.
    Dean G; Brady R; McLoughlin H
    Br J Prev Soc Med; 1977 Sep; 31(3):141-7. PubMed ID: 588852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
    Chancellor AM; Swingler RJ; Fraser H; Clarke JA; Warlow CP
    J Epidemiol Community Health; 1993 Apr; 47(2):116-20. PubMed ID: 8326268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of activity and participation across neurodegenerative conditions: a comparison of people with motor neurone disease, multiple sclerosis and Parkinson's disease.
    Morley D; Dummett S; Kelly L; Fitzpatrick R; Jenkinson C
    BMC Neurol; 2018 Feb; 18(1):19. PubMed ID: 29454326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis, Parkinson's disease and multiple sclerosis.
    Ajdacic-Gross V; Schmid M; Tschopp A; Gutzwiller F
    Neuroepidemiology; 2012; 38(1):56-63. PubMed ID: 22236983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How can the national burden of Parkinson's disease comorbidity and mortality be estimated for the Japanese population?
    Doi Y; Yokoyama T; Nakamura Y; Nagai M; Fujimoto K; Nakano I
    J Epidemiol; 2011; 21(3):211-6. PubMed ID: 21422700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel biomarker for neurodegenerative diseases- motor neuron disease (MND), cerebellar ataxia (CA) and Parkinson's disease (PD).
    Pandey S; Singh B; Yadav SK; Mahdi AA
    Clin Chim Acta; 2018 Oct; 485():258-261. PubMed ID: 30006282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.